<p><strong>Symptoms</strong>: Prolonged apnoea, resp depression and/or muscle weakness. Death may follow acute resp failure.<br />
<br />
<strong>Management:</strong>&nbsp;May administer neostigmine 2.5 mg and atropine 1.2 mg to reverse neuromuscular block while ventilation is continued. When admin of the anticholinesterase agent fails to reverse neuromuscular blockade, continue ventilation until spontaneous breathing is restored.</p>